Publications by authors named "Veronique Marsaud"

Claim this Profile
S
Sonic hedgehog medulloblastomas are dependent on Netrin-1 for survival.
Julie Talbot, Joanna Fombonne, Jacob Torrejon, Benjamin R Babcock, Leon F McSwain, Veronique Marsaud

Nat Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression.
Ryo Shiraishi, Gabriele Cancila, Kohei Kumegawa, Jacob Torrejon, Irene Basili, Véronique Marsaud

Dev Cell· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteogenomic profiling uncovers differential therapeutic vulnerabilities between and translocated B-cell acute lymphoblastic leukemia.
Lena Blumel, Flavia Bernardi, Daniel Picard, Jacob Torrejon Diaz, Vera H Jepsen, Veronique Marsaud

Haematologica· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
Ezequiel J Tolosa, Maite G Fernandez-Barrena, Eriko Iguchi, Angela L McCleary-Wheeler, Ryan M Carr, Veronique Marsaud

Biochem J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale pan-cancer analysis reveals broad prognostic association between TGF-β ligands, not Hedgehog, and GLI1/2 expression in tumors.
Aurélien de Reyniès, Delphine Javelaud, Nabila Elarouci, Véronique Marsaud, Cristèle Gilbert

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional repression of the tyrosinase-related protein 2 gene by transforming growth factor-β and the Kruppel-like transcription factor GLI2.
Marie-Jeanne Pierrat, Véronique Marsaud, Alain Mauviel, Delphine Javelaud

J Dermatol Sci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress.
Clémence Coudre, Julien Alani, William Ritchie, Véronique Marsaud, Brigitte Sola

Cell Cycle· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell density sensing alters TGF-β signaling in a cell-type-specific manner, independent from Hippo pathway activation.
Flore Nallet-Staub, Xueqian Yin, Cristèle Gilbert, Véronique Marsaud, Saber Ben Mimoun

Dev Cell· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Flore Nallet-Staub, Véronique Marsaud, Ling Li, Cristèle Gilbert, Sophie Dodier

J Invest Dermatol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
Carole Y Perrot, Cristèle Gilbert, Véronique Marsaud, Antonio Postigo, Delphine Javelaud

Pigment Cell Melanoma Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Hydroxy-tamoxifen-loaded liposomes have potent anti-myeloma activity.
Giorgia Urbinati, Véronique Marsaud, Jack-Michel Renoir, Brigitte Sola

Leuk Lymphoma· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism.
Brigitte Sola, Marc Poirot, Philippe de Medina, Sophie Bustany, Véronique Marsaud

Oncotarget· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer drugs in liposomal nanodevices: a target delivery for a targeted therapy.
Giorgia Urbinati, Veronique Marsaud, Jack-Michel Renoir

Curr Top Med Chem· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor signaling as a target for novel breast cancer therapeutics.
Jack-Michel Renoir, Véronique Marsaud, Gwendal Lazennec

Biochem Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β.
Marie-Jeanne Pierrat, Véronique Marsaud, Alain Mauviel, Delphine Javelaud

J Biol Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal trichostatin A: therapeutic potential in hormone-dependent and -independent breast cancer xenograft models.
Giorgia Urbinati, Véronique Marsaud, Valérie Nicolas, Juliette Vergnaud-Gauduchon, Jack-Michel Renoir

Horm Mol Biol Clin Investig· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEGylation and preliminary biocompatibility evaluation of magnetite-silica nanocomposites obtained by high energy ball milling.
Martina Pilloni, Julien Nicolas, Véronique Marsaud, Kawthar Bouchemal, Francesca Frongia

Int J Pharm· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy.
Giorgia Urbinati, Véronique Marsaud, Vincent Plassat, Elias Fattal, Sylviane Lesieur

Int J Pharm· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor alpha and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts.
Céline Bouclier, Véronique Marsaud, Olivia Bawa, Valérie Nicolas, Laurence Moine

Breast Cancer Res Treat· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin K and cyclin D1b are oncogenic in myeloma cells.
Véronique Marsaud, Guergana Tchakarska, Geoffroy Andrieux, Jian-Miao Liu, Doulaye Dembele

Mol Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging.
Davide Brambilla, Julien Nicolas, Benjamin Le Droumaguet, Karine Andrieux, Véronique Marsaud

Chem Commun (Camb)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.
Raquel Díaz-López, Nicolas Tsapis, Mathieu Santin, Sharon Lori Bridal, Valérie Nicolas, Véronique Marsaud

Biomaterials· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging.
Patricia Horcajada, Tamim Chalati, Christian Serre, Brigitte Gillet, Catherine Sebrie, Veronique Marsaud

Nat Mater· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of new 4-hydroxy-tamoxifen-loaded pH-gradient liposomes in a multiple myeloma experimental model.
Giorgia Urbinati, Davide Audisio, Véronique Marsaud, Vincent Plassat, Silvia Arpicco

Pharm Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
L Harivardhan Reddy, Jack-Michel Renoir, Veronique Marsaud, Sinda Lepetre-Mouelhi, Didier Desmaële

Mol Pharm· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis